Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

Allele-Specific Expression of Leukemia Genes Is Associated with Pathogenicity in Poor Risk AML

Blood (2023) 142 (Supplement 1): 1389.

https://doi.org/10.1182/blood-2023-184516

Published: 2023

Journal Articles

The XPO1-FOXC1-HOX Functional Axis Opens New Therapeutic Avenues to Treat DEK-NUP214 AML Patients

Blood (2023) 142 (Supplement 1): 4302.

https://doi.org/10.1182/blood-2023-174891

Published: 2023

Journal Articles

Longitudinal Single Cell Analyses Reveal the Co-Evolutionary Dynamics of the Tumor and Microenvironment Accompanying Follicular Lymphoma Transformation

Megan Perrett, Lucy Pickard, Emil Kumar, Giuseppe Palladino, Faraz Khan, Carina Edmondson, Connor Knight, Edward Poynton, Janet Matthews, Shamzah Araf, Andrew James Clear, Maria Calaminici, John G. Gribben, Hamish King, Mirjana Efremova, Jun Wang, Jessica Okosun

Blood (2022) 140 (Supplement 1): 748–749.

https://doi.org/10.1182/blood-2022-159995

Published: 2022

Journal Articles

Deep Multi-Omics Profiling in Cytogenetically Poor-Risk AML

Blood (2022) 140 (Supplement 1): 1030–1032.

https://doi.org/10.1182/blood-2022-159069

Published: 2022

Journal Articles

Integration of Deep Multi-Omics Profiling Veals New Insights into the Biology of Poor-Risk Acute Myeloid Leukemia

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-141345

Published: 2020

Journal Articles

Deep Phenotypic Analysis Reveals a Monocyte Subpopulation Predictive of Relapse/Refractory Diffuse Large B-Cell Lymphoma

Edward Truelove, MBBS, BSc, MRCP, FRCPath, Frances Seymour, MRCP, BSc, MBBS, Janet Matthews, John G. Gribben

Blood (2018) 132 (Supplement 1): 2863.

https://doi.org/10.1182/blood-2018-99-119756

Published: 2018

Journal Articles

The Treg/Th17 Axis Is Skewed in Classical Hodgkin Lymphoma By PDL1+Ve but Not PDL1-Ve Lymphoma Cells and By Lymphoma MHC Class 2 Expression.

Joseph G Taylor, MBBS, BSc, Andrew James Clear, BSc, Janet Matthews, Mariarita Calaminici, John G. Gribben

Blood (2018) 132 (Supplement 1): 4124.

https://doi.org/10.1182/blood-2018-99-119126

Published: 2018

Journal Articles

TNFRSF14 aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses

Eleni Kotsiou, Jessica Okosun, Caroline Besley, Sameena Iqbal, Janet Matthews, Jude Fitzgibbon, John G. Gribben, Jeffrey K. Davies

Blood (2016) 128 (1): 72–81.

https://doi.org/10.1182/blood-2015-10-679191

Published: 2016

Includes: Supplemental data

Journal Articles

Overexpression of HMGB1 Receptor RAGE Is Associated with Worse Clinical Outcome in Patients with Chronic Lymphocytic Leukemia

Faith Norster, MBiochem, Andrew James Clear, BSc, Janet Matthews, Elena Hoxha, MSc, John Gribben, MDDSc, Li Jia, PhD MD

Blood (2015) 126 (23): 617.

https://doi.org/10.1182/blood.V126.23.617.617

Published: 2015

Journal Articles

Overexpression of BCL-2 Does Not Inhibit Autophagy in Human Follicular and Diffuse Large B-Cell Lymphomas

Aine McCarthy, PhD, Andrew James Clear, BSc, Jacek Marzec, Rita Coutinho, MD, Robert D. Petty, PhD, Janet Matthews, Andrew Wilson, Sameena Iqbal, Maria Calaminici, MD PhD, John G. Gribben, MD DSc, Li Jia, PhD MD

Blood (2014) 124 (21): 3007.

https://doi.org/10.1182/blood.V124.21.3007.3007

Published: 2014

Journal Articles

Extracellular HMGB1 promotes differentiation of nurse-like cells in chronic lymphocytic leukemia

Li Jia, Andrew Clear, Feng-Ting Liu, Janet Matthews, Nadiha Uddin, Aine McCarthy, Elena Hoxha, Catherine Durance, Sameena Iqbal, John G. Gribben

Blood (2014) 123 (11): 1709–1719.

https://doi.org/10.1182/blood-2013-10-529610

Published: 2014

Includes: Supplemental data

Journal Articles

Psychosocial Factors and Impact Of Cancer In British Long-Term Haematological Cancer Survivors

Ania Korszun, PhD, MD, FRCPsych, Shah-Jalal Sarker, PhD, FHEA, Kashfia Chowdhury, MSc, Charlotte Clark, PhD, CPsychol, Paul Greaves, MD, Rachel Johnson, Judith Kingston, Gill Levitt, MD, FRPCh, Janet Matthews, Peter White, MD, FRCP, FRCPscyh, Andrew Lister, John Gribben, MD, DSc

Blood (2013) 122 (21): 2943.

https://doi.org/10.1182/blood.V122.21.2943.2943

Published: 2013

Journal Articles

Concurrent Follicular Lymphoma At Diagnosis Has a Negative Impact On The Outcome Of Patients With Diffuse Large B Cell Lymphoma

David Wrench, MD, PhD, Hasan Rizvi, MD, Andrew Wilson, Ciaran O'Riain, MD, PhD, Andrew Clear, Janet Matthews, Daniele Laszlo, MD, T. Andrew Lister, MD, John G. Gribben, MD, DSc, FRCP, FMedSci, FRCPath, Maria Calaminici, MD, PhD, Silvia Montoto, MD

Blood (2013) 122 (21): 4260.

https://doi.org/10.1182/blood.V122.21.4260.4260

Published: 2013

Journal Articles

EZH2 mutations are frequent and represent an early event in follicular lymphoma

Blood (2013) 122 (18): 3165–3168.

https://doi.org/10.1182/blood-2013-04-496893

Published: 2013

Includes: Supplemental data

Journal Articles

Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells

Paul Greaves, Andrew Clear, Andrew Owen, Sameena Iqbal, Abigail Lee, Janet Matthews, Andrew Wilson, Maria Calaminici, John G. Gribben

Blood (2013) 122 (16): 2856–2863.

https://doi.org/10.1182/blood-2013-06-508044

Published: 2013

Includes: Supplemental data

Journal Articles

P110α-mediated constitutive PI3K signaling limits the efficacy of p110δ-selective inhibition in mantle cell lymphoma, particularly with multiple relapse

Sunil Iyengar, Andrew Clear, Csaba Bödör, Lenushka Maharaj, Abigail Lee, Maria Calaminici, Janet Matthews, Sameena Iqbal, Rebecca Auer, John Gribben, Simon Joel

Blood (2013) 121 (12): 2274–2284.

https://doi.org/10.1182/blood-2012-10-460832

Published: 2013

Journal Articles

Increased Tonic PI3K Signaling Through p110α Can Limit the Efficacy of P110δ-Selective Inhibition in Mantle Cell Lymphoma, Particularly with Multiple Relapse

Sunil Iyengar, MD, Andrew James Clear, BSc, Csaba Bödör, PhD, Lenushka Maharaj, Janet Matthews, Rebecca Auer, MD, Sameena Iqbal, John G Gribben, Simon Joel

Blood (2012) 120 (21): 1652.

https://doi.org/10.1182/blood.V120.21.1652.1652

Published: 2012

Journal Articles

The Relationship of Depression and Anxiety and Impact of Cancer in Long-Term Survivors of Haematological Malignancy.

Ania Korszun, Rachel Johnson, Shah-Jalal Sarker, Chowdhury Kashfia, Charlotte Clark, Paul Greaves, MD, Judith Kingston, Gill Levitt, Janet Matthews, Rebecca Matthews, Matthew Smith, John G Gribben, T. Andrew Lister

Blood (2012) 120 (21): 3174.

https://doi.org/10.1182/blood.V120.21.3174.3174

Published: 2012

Journal Articles

The Diffuse Large B-Cell Lymphoma Infiltrating Macrophage Transcriptome Signature Is Enriched for Both M1 and M2 Genes and Provides an Excellent Platform for Functional Validation of Macrophage Biology in DLBCL

Rita Coutinho, MD, Aaron M. Newman, PhD, Guglielmo Rossignoli, PhD, William Day, MsC, Faridah Miraki-Moud, PhD, Tracy Chaplin, Jacek Marzec, Robert D. Petty, Sameena Iqbal, Janet Matthews, Ash A. Alizadeh, MD, PhD, John G Gribben

Blood (2012) 120 (21): 790.

https://doi.org/10.1182/blood.V120.21.790.790

Published: 2012

Journal Articles

High Incidence of EZH2 Mutations with Variable Mutation Load in Follicular Lymphoma and Its Consequences for EZH2 Targeted Therapy

Blood (2012) 120 (21): 545.

https://doi.org/10.1182/blood.V120.21.545.545

Published: 2012

NARROW

Allele-Specific Expression of Leukemia Genes Is Associated with Pathogenicity in Poor Risk AML

The XPO1-FOXC1-HOX Functional Axis Opens New Therapeutic Avenues to Treat DEK-NUP214 AML Patients

Longitudinal Single Cell Analyses Reveal the Co-Evolutionary Dynamics of the Tumor and Microenvironment Accompanying Follicular Lymphoma Transformation

Deep Multi-Omics Profiling in Cytogenetically Poor-Risk AML

Integration of Deep Multi-Omics Profiling Veals New Insights into the Biology of Poor-Risk Acute Myeloid Leukemia

Deep Phenotypic Analysis Reveals a Monocyte Subpopulation Predictive of Relapse/Refractory Diffuse Large B-Cell Lymphoma

The Treg/Th17 Axis Is Skewed in Classical Hodgkin Lymphoma By PDL1+Ve but Not PDL1-Ve Lymphoma Cells and By Lymphoma MHC Class 2 Expression.

TNFRSF14 aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses

Overexpression of HMGB1 Receptor RAGE Is Associated with Worse Clinical Outcome in Patients with Chronic Lymphocytic Leukemia

Overexpression of BCL-2 Does Not Inhibit Autophagy in Human Follicular and Diffuse Large B-Cell Lymphomas

Extracellular HMGB1 promotes differentiation of nurse-like cells in chronic lymphocytic leukemia

Psychosocial Factors and Impact Of Cancer In British Long-Term Haematological Cancer Survivors

Concurrent Follicular Lymphoma At Diagnosis Has a Negative Impact On The Outcome Of Patients With Diffuse Large B Cell Lymphoma

EZH2 mutations are frequent and represent an early event in follicular lymphoma

Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells

P110α-mediated constitutive PI3K signaling limits the efficacy of p110δ-selective inhibition in mantle cell lymphoma, particularly with multiple relapse

Increased Tonic PI3K Signaling Through p110α Can Limit the Efficacy of P110δ-Selective Inhibition in Mantle Cell Lymphoma, Particularly with Multiple Relapse

The Relationship of Depression and Anxiety and Impact of Cancer in Long-Term Survivors of Haematological Malignancy.

The Diffuse Large B-Cell Lymphoma Infiltrating Macrophage Transcriptome Signature Is Enriched for Both M1 and M2 Genes and Provides an Excellent Platform for Functional Validation of Macrophage Biology in DLBCL

High Incidence of EZH2 Mutations with Variable Mutation Load in Follicular Lymphoma and Its Consequences for EZH2 Targeted Therapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only